Noncompliance with medical treatment among glaucoma patients in Oman - A cross-sectional descriptive study

Ophthalmic Epidemiology

Volumn 12, Issue 5, 2005, Pages 303-309

  Khandekar, Rajiv ^a,b   Shama, Mona El Sayed ^a   Mohammed, Ali Jaffer ^a  

^a MINISTRY OF HEALTH   (Oman)

^b NCD   (Oman)

Author keywords

Eyedrops; Glaucoma treatment; Oman; Questionnaire study; Treatment compliance; Underdeveloped countries

Indexed keywords

EYE DROPS; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GLAUCOMA; HEALTH EDUCATION; HUMAN; INFANT; MALE; OMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT REFUSAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GLAUCOMA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; OMAN; QUESTIONNAIRES; TREATMENT REFUSAL;

EID: 28244491460     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580500224602     Document Type: Article

References (20)

1. Report on the conference on 'Vision 2020 Planning for the Eastern Mediterranean Region,' Dec. 2003, Cairo, Egypt. (WHO/EMR/PBL/ 03.1) (http://whilibdoc.who.EMR/2003/WHOPBLy03.1.pdf).
2. Khandekar R, Mohammed AJ, Negrel AD, Al Raiyami A. The prevalence and causes of blindness in the Sultanate of Oman: the Oman Eye study (OES). Br J Ophthalmol. 2002;86(9):957-962.
3. Ministry of Health Oman Eye Health Care Manual, 2nd ed. Al Zahra Printers, 2000;20-22.
4. Spooner JJ, Bullano MF, Ikeda LI, et al. Rates of discontinuation and change of glaucoma therapy in a managed care setting. Am J Manag Care. 2002;8(10 Suppl):S262-270.
5. Patel SC, Spaeth GL. Compliance in patients prescribed eye drops for glaucoma. Ophthalmic Surg. 1995;26(3):233-236.
6. Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye. 1998;12(Pt 2):234-236.
7. Ministry of Health, Sultanate of Oman. Annual Health Report for the year 2003. Oman: Ministry of Health, 2004;8-41.
8. Ministry of Health, Sultanate of Oman. Methodology Manual of the National Survey for Glaucoma in Oman. Oman: National Printers, 2004; 2-6.
9. Fletcher RH. Patient compliance with therapeutic advice: a modern view. Mt Sinai J Med. 1989;56(6):453-458.
10. De Geest S, Dobbels F, Martin S, et al. Clinical risk associated with appointment noncompliance in heart transplant recipients. Prog Transplant. 2000;10(3):162-168.
11. Wilson TG Jr, Hale S, Temple R. The results of efforts to improve compliance with supportive periodontal treatment in a private practice. J Periodontol. 1993;64(4):311-314.
12. Gurwitz JH, Yeomans SM, Glynn RJ, et al. Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care. 1998;36(3):357-369.
13. Bloch S, Rosenthal AR, Friedman L, Caldarolla P. Patient compliance in glaucoma. Br J Ophthalmol. 1977;61(8):531-534.
14. Aziz AM, Ibrahim MI. Medication noncompliance - a thriving problem. Med J Malaysia. 1999;54(2):192-199.
15. Lau JT, Lee V, Fan D, et al. Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population. Br J Ophthalmol. 2002;86(10):1080-1084.
16. Cooper J. Improving compliance with glaucoma eye-drop treatment. Nurs Times. 1996;92(32):36-37.
17. Lee MD, Fechtner FR, Fiscella RG, et al. Emerging perspectives on glaucoma: highlights of a roundtable discussion. Am J Ophthalmol. 2000;130(4 Suppl):S1-11.
18. Granstrom PA. Progression of visual field defects in glaucoma. Relation to compliance with pilocarpine therapy. Arch Ophthalmol. 1985;103(4):529-531.
19. Norell SE, Granstrom PA. Self-medication with pilocarpine among outpatients in a glaucoma clinic. Br J Ophthalmol. 1980;64(2):137-141.
20. Chang JS Jr, Lee DA, Petursson G, et al. The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure. J Ocul Pharmacol. 1991;7(2):117-124.